These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2581383

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The pharmacological profile of a specific, safe, effective and non-sedative anti-allergic, astemizole.
    Niemegeers CJ, Awouters F, Janssen PA.
    Agents Actions; 1986 Apr; 18(1-2):141-4. PubMed ID: 2873722
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
    Fügner A, Bechtel WD, Kuhn FJ, Mierau J.
    Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
    [Abstract] [Full Text] [Related]

  • 7. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B, Dordal A, Fort M, Galicia J, Farré AJ.
    Methods Find Exp Clin Pharmacol; 1996 Oct; 18(6):397-406. PubMed ID: 8892269
    [Abstract] [Full Text] [Related]

  • 8. Pharmacology of the specific histamine H1-antagonist astemizole.
    Awouters FH, Niemegeers CJ, Janssen PA.
    Arzneimittelforschung; 1983 Oct; 33(3):381-8. PubMed ID: 6135428
    [No Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
    Laduron PM, Janssen PF, Gommeren W, Leysen JE.
    Mol Pharmacol; 1982 Mar; 21(2):294-300. PubMed ID: 6124876
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Astemizole: its pharmacokinetics and pharmacologic properties].
    Levron JC, Gillardin JM, Sabbah A.
    Allerg Immunol (Paris); 1990 Jun; 22(6):233-41. PubMed ID: 1974137
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
    Leysen JE, Gommeren W, Janssen PF, Sanz G, Gillardin JM, Schotte A, Janssen PA.
    Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
    [Abstract] [Full Text] [Related]

  • 14. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J, Duval D, Prouteau M, Voltz C, Berry CN, Lloyd KG, Scatton B.
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T, Saito T, Tajima S, Shimohara K, Ito K.
    Arzneimittelforschung; 1984 May; 34(7):805-10. PubMed ID: 6208915
    [Abstract] [Full Text] [Related]

  • 17. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K, Kamei C, Akagi M, Mio M, Shirasaka T, Chokki M.
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.